The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
Authors
Keywords
Journal
Oncotarget
Volume 6, Issue 22, Pages -
Publisher
Impact Journals, LLC
Online
2015-09-15
DOI
10.18632/oncotarget.4303

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.